You searched for "laser"

5761 results found

Mainline Instruments Partners with InMode to bring ENVISION to the UK & Ireland

We are excited to entering our new partnership with InMode, a global leader in medical technologies, to distribute the ENVISION Dry Eye care platform across the UK and Ireland. Envision is a state-of-the-art system that combines IPL and Radiofrequency to...

Glaukos marks major milestone as global iStent sales reach 3 million

Glaukos is delighted to announce a major milestone revealing that 3 million iStents have been sold globally since the product first received approval from the FDA in 2012. Today iStent is the global market leader in the MIGs category with...

My Top Five: Tips for a successful grant application in ophthalmology

Securing funding for an educational or research initiative in ophthalmology can often feel like a competitive, confusing and time-intensive task. Whether you’re an early-career researcher looking to get your first project off the ground or an experienced educator aiming to...

OSA chair passes to a delighted James Conway

Longstanding OSA Director James Conway is delighted to have been appointed as the new OSA Chair, following the retirement of Roy Stoner after a three-year tenure. The OSA’s AGM and Christmas lunch at the Bloomsbury Hotel, London, saw Roy pass...

Chorioretinal atrophy in punctate inner choroidopathy / multifocal choroiditis

This study reported the five-year outcomes of chorioretinal atrophy (CRA) progression in patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) in 45 eyes of 36 patients. The mean age of the cohort of patients was 37 ±13.37 years...

Which cover test method is the best starting point for prescribing temporary prisms?

A retrospective review of medical records was completed, identifying consecutive patients prescribed Fresnel prisms for diplopia, assessed using both simultaneous prism and cover test (SPCT) and prism and alternate cover test (PACT) by a single orthoptist over a 36-month period....

Nordic Pharma Announces CE Mark Approval for Lacrifill® Canalicular Gel, Paving the Way for European Launch

Nordic group B.V – an international pharmaceutical company operating as Nordic Pharma have received CE mark approval for Lacrifill®, a novel dry eye therapy. Lacrifill® is a cross-linked hyaluronic acid gel that temporarily blocks tear drainage by occluding the canalicular...

One-week intubation in external dacryocystorhinostomy

Whether to routinely intubate or not in dacryocystorhinostomy (DCR) surgery has been a subject of controversy among lacrimal surgeons. Similarly, if intubated the timing of removal of stent is not standard. Here, the authors carried out a survey of their...

The invisible touch: a VISION 2020 LINK with Indonesia

Indonesia’s population, the world’s fourth largest, is spread across 6,000 inhabited islands. Whilst some areas (e.g. Kalimantan, Papua) are relatively sparsely populated, Java is the world’s most densely populated island, with twice the population of the UK in half the...

Ophthalmic mentors: Professor Sir Peng Tee Khaw

In the second of our interviews in this series, Eye News speaks to Professor Sir Peng Tee Khaw, Professor of Glaucoma and Ocular Healing, Consultant Ophthalmic Surgeon, Director of the National Institute for Health Research, Biomedical Research Centre at Moorfields...

Unilateral central scotoma following dengue fever

Case report A 16-year-old Caucasian male was referred to the eye casualty at Nottingham University Hospitals NHS Trust by the infectious diseases unit in September 2013. He gave a history of photophobia, pain on eye movements and central blurred vision...

Immunotherapy for orbital SCC

In the UK, cemiplimab is recommended for treating metastatic or locally advanced cutaneous squamous cell carcinoma (SCC) in adults when curative surgery or curative radiotherapy is not suitable. Pembrolizumab is recommended as an option for untreated metastatic or unresectable recurrent...